Skip to main content
OpenTrials

Clinical trial condition

Poxviridae Infections

Explore clinical trials studying Poxviridae Infections. Study availability and eligibility vary by location and protocol.

166 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Poxviridae Infections trial results

Completed

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

NCT01394939

Conditions
CRC, Colonic Diseases, Colonic Neoplasms, +17 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Billings Clinic Cancer Center Billings, Montana, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

NCT01387555

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Moores University of California San Diego Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
View all 38 locations
View Trial Details
Completed

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

NCT02562755

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
View all 142 locations
View Trial Details
Completed

Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact

NCT05376527

Conditions
Breast Diseases, Breast Neoplasms, DNA Virus Infections, +9 more
Locations
  • N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation Moscow, Russia
  • National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation Obninsk, Russia
  • N.N. Petrov National Medical Research Center of Oncology Saint Petersburg, Russia
  • Oncology Research Center, LLC Saint Petersburg, Russia
View Trial Details
Completed

Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

NCT05512949

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • University of California, San Diego (UCSD) - Antiviral Research Center (AVRC) San Diego, California, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • NIH Clinical Research Center, Investigational Drug Management and Research Section Bethesda, Maryland, United States
View Trial Details

Related conditions